UBC cannabis services spinout Anandia has been acquired by marijuana distributor Aurora Cannabis for $86.5m as Canada prepares to legalise the drug for recreational purposes.

Immuno-oncology drug developer iTeos Therapeutics has secured funding in a 6 Dimensions Capital-backed series B round.

Iowa State's Startup Factory Network will train ten startups over 52 weeks at ISU Research Park, while another eight businesses will participate remotely from northern Iowa.

Codelucida, Regulonix and Post.Bid.Ship have all been backed by UAVenture Capital.

UZH-founded skin graft creator Cutiss has welcomed series A investors led by Giammaria Giuliani in a bid to provide improved healing of dermatological scars left by reconstructive or plastic surgery.

GCV Analytics defines the health sector as encompassing pharmaceuticals, medical and diagnostic devices, healthcare IT and administration, care provision and on-demand services as well as other health businesses.

Existing investor FoxKiser has returned for a $32.5m round that follows the cancer immunotherapy T cell developer's series A two years ago.

Stealth has secured $100m in convertible note financing across two rounds, one of which was led by Nan Fung Technology's Pivotal Beta.

Decibel Therapeutics, which is developing drugs to combat hearing loss, raised the cash in a round that included SR One, Regeneron and GV.